Your browser doesn't support javascript.
loading
Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis.
Soyka, Michael B; Ryser, Fabio S; Brühlmann, Catrin; Fehr, Danielle; Dülgeroglu, Jacqueline; Schmid-Grendelmeier, Peter; Brüggen, Marie-Charlotte; Steiner, Urs C.
Afiliação
  • Soyka MB; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Ryser FS; Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Brühlmann C; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Fehr D; Allergy Unit, Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Dülgeroglu J; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • Schmid-Grendelmeier P; Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.
  • Brüggen MC; Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Steiner UC; Allergy Unit, Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Allergy ; 78(4): 1036-1046, 2023 04.
Article em En | MEDLINE | ID: mdl-36161658

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sinusite / Rinite / Pólipos Nasais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sinusite / Rinite / Pólipos Nasais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça